Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS3917452 A
Publication typeGrant
Publication dateNov 4, 1975
Filing dateNov 25, 1974
Priority dateDec 20, 1973
Also published asCA1027832A1, DE2363344A1, DE2363344B2
Publication numberUS 3917452 A, US 3917452A, US-A-3917452, US3917452 A, US3917452A
InventorsWalter Rittersdorf, Werner Guthlein, Hans-Georg Rey, Peter Rieckmann
Original AssigneeBoehringer Mannheim Gmbh
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Diagnostic agent for the detection of peroxidatively active substances
US 3917452 A
Abstract
Test strips for the detection of peroxidatively active substances in body fluids, e.g., for the detection of blood in urine, comprising a carrier containing A. A HYDROPEROXIDE; B. AT LEAST ONE CHROMOGEN; AND C. AS AN ACTIVATOR A COMPOUND OF THE FORMULA:
Images(4)
Previous page
Next page
Description  (OCR text may contain errors)

' United States Patent 1 Rittersdorf et al.

[ 1 Nov. 4, 1975 [73] Assignee: Boehringer Mannheim GmbH,

Mannheim, Germany 22 Filed: Nov. 25, 1974 21 Appl. No.: 526,661

[30] Foreign Application Priority Data Dec. 20, 1973 Germany 2363344 [52] US. Cl. 23/230 B; 23/253 TP; 195/103.5;

[51] Int. CL? .,C07D 213/24; GOIN 31/22; GOIN 33/16 [58] Field of Search 23/230 B, 253 TP; 195/103.5; 252/408; 260/240 D, 240 E [56] References Cited UNITED STATES PATENTS 3,558,435 1/1971 Rey et a1. .4 23/230 B X 3,630,847 12/1971 Rey et a1 23/230 B X 3,654.179 4/1972 Bauer i 23/230 B X 3,654.180 4/1972 Bauer 23/230 B X 3.853.471 12/1974 Rittersdorf et al. 23/230 B Primary Examiner-Robert M. Reese Attorney, Agent, or FirmBurgess, Dinklage & Sprung [57] ABSTRACT Test strips for the detection of peroxidatively active substances in body fluids, e.g., for the detection of blood in urine, comprising a carrier containing a. a hydroperoxide;

b. at least one chromogen; and

c. as an activator a compound of the formula:

wherein R is pyridyl or phenyl, optionally substituted by lower alkyl or alkoxy, and R is hydrogen or lower alkyl.

25 Claims, No Drawings DIAGNOSTIC AGENT FOR THE DETECTION OF PEROXIDATIVELY ACTIVE SUBSTANCES The present invention relates to a test strip for the de tection of very small amounts of blood and of other peroxidatively-active substances in the body fluids.

The detection of small amounts of blood, which cannot be seen by the naked eye, in urine, feces and vomit is very important for the diagnosis of hemorrhages in the stomach, intestines and urinary tract. Such hemorrhages are caused, for example, by tumors, ulcers or inflammations in the organs in question. Furthermore, due to the .influence of certain hemolytic toxins, free hemoglobin can also occur in the urine and plasma. Blood and hemoglobin are .peroxidatively-active, i.e., they liberate oxygen from hydroperoxides and transfer it to certain acceptors. Myoglobin, which is also peroxidatively-active, is found, for example, in the urine after a cardiac infarct. Furthermore, blood occurs especially frequently in the urine when calculi are present in the bladder or kidneys. I

For asensitive detection of all of these substances, their peroxidate action is especially suitable. The oxygen liberated from a hydroperoxide is thereby transmitted to a chromogen which is oxidized to a color mate rial and thus indicates the presence of the peroxidative ly-active substances. This reaction has been used for quite a long time in medicinal and forensic analysis, especially for the detection of blood. As a rule, the reaction is carried out in a test tube or as a spot test, hydrogen peroxide usually being employed as the hydroper oxide. As chromogen, there is usually employed benzidine, o-tolidine or leucomalachite green.

Rapid test compostions are absorbent carriers, usually papers, which are impregnated with all the reagents needed for the detection reaction and which, after simply dipping into the body fluid to be tested, show a color reaction. Because of the great importance which these rapid tests have recently achieved, they have also been developed in various ways for the detection of blood in body fluids.

Since, for the detection of blood, the sensitivity of the rapid test is of decisive importance, various attempts have already been made to increase the sensitivity of the known detection reactions by means of additives. Thus, for example, German Pat. Spec. No. 1,242,905 describes test papers which, as activating additives, contain certain quinoline derivatives, preferably quinine. It is certainly asserted that the sensitivity can be considerably increased by means of these additives but, according to our own investigations, it is practically impossible, with the so improved tests strips, to detect, for example, blood in a concentration of 5 erythrocytes /mm", which would be necessary for a differentiation between normal and pathological values.

We have now found that test papers for the detection of peroxidatively-active substances with a previously unachievably high sensitivity are obtained by utilizing certain vinylpyridine compounds as activators.

The vinyl pyridine compounds showing this efficacious action are of the formula wherein R is pyridyl or phenyl, optionally substituted by lower alkyl or alkoxy, and

R is hydrogen or lower alkyl.

Preferred compounds of general formula (I) are those in which R, is hydrogen. The lower alkyl and alkoxy radicals can contain up to 4 carbon atoms, the methyl and methoxy radicals being preferred.

Thus, according to the present invention, there is provided a test strip for the detection of peroxidativelyactive substances in body fluids, comprising a carrier containing a hydroperoxide, at least one chromogen and, as activator, at least one compound of general formula (I).

The sensitivity of the detection reaction is increased by some of the compounds of general formula (I) to such an extent that it is even possible to detect individual erythrocytes in urine, which are visible on the test paper as colored dots. Thus, for example, with the use of a-styryl-pyridine, it is possible to produce a test paper with which it is possible to detect 5 erythrocytes/mm urine. This corresponds to a blood dilution of 1110.

Of course, not all of the compounds of general formula (I) possess activating properties of the same degree. Thus, it is possible to adjust the sensitivity of, for example, a blood test in accordance with practical requirements. For example, test strips of increasing activity are obtained when, as activator, there are used the following compounds in the given order:

2-( phenylvinyl )-4-methylpyridine Pyridyl-Z-pyridyl-4-ethylene 2-( methylphenylvinyl)-pyridilne 2-(4-methoxyphenylvinyl) pyridine di-(pyridyl-2)-ethylene pyridyl-2-pyridyl-3-ethylene oz-styryl-pyridine.

The activating agent used according to the present invention can be employed in amounts of about 0.05 1.0g, preferably of 0.2 0.5g, per ml. ofimpregnation solution.

Further components of a rapid test for blood are an organic hydroperoxide, an oxidation indicator (chromogen), a buffer and a surface-active agent, as well as, if desired, a phosphoramide, for example phosphoric acid trimorpholide, for stabilization, as well as conventional adjuvants.

As hydroperoxides, there can be used, for example, diisopropyl-benzene hydroperoxide or 2,5-dimethylhexane-2,S-dihydroperoxide, and as indictors, there can be used, for example, those of the benzidine series, such as o-tolidine, or those of the heterocylic azine series, such as bis-(N-ethyl-quinol-Z-one)-azine or (N- methyl-benz-thiazol-2-one)-(1-ethyl-3-phenyl-5- methyltriazol-Z-one)-azine (see German Pat.Spec No. 1,648,840).

The indicator (chromogen) can be used in amounts of from 0.05 g., preferably of 0.2 1.0 g., per 100 ml. impregnation solution.

As buffer, there can be used, for example, a citrate. phosphate, phthalate or succinate buffer. the pH value and capacity being so chosen that. after dipping the test strip into a body fluid, a pH value of 4 7. preferably 5 3 6, is obtained thereon.

it is also advantageous to add to the formulation small amounts (for example about 0.05 0.5 g. per 100 ml.) ofa complex-forming agent, for example, sodium metaphosphate or ,ethylenediamine-tetraacetic acid, in order to avoid falsely positive reactions which could be caused bytraces of metals.

Since the test papers can, because of the relatively large amounts 7 of water-soluble substances present, tend to bleed, it is practical to add to the formulation a thickening agent, for example, methyl cellulose and, in particular, polyvinylpyrrolidone, preferably in amounts of about 0.5 5 g. per 100 ml. g I

wetting agent, there is preferably used a longchainedorganic sulphate or sulphonate, for example sodium 'dodecyl-benzenesulphonate, dioctyl sodium sulphosuccinate or sodium lauryl sulphate, which, as is known, stabilizes radical cations, such as oxidized otolidine. The wetting agent can be added to the impregnation solutionin amounts of from 0.5 5%, preferably of'l 3%. I

For the production of the test strips according to the present invention, absorbentcarriers, for example, filter paper, cellulose or synthetic fibre fleeces, can be impregnated with solutions of the reagents'in readily volatile liquids. This is preferably carried out in two or three separate steps. Thus, for example, impregnation is first carried out with a solution which contains a hydroperoxide, wetting agent, buffer and optionally a thickening agent. Thereafter, impregnation is carried out witha solution of an indicator and of an activator of general formula (1).

After drying, the test strips according to the present invention are cut up into strips and preferably sealed between a synthetic resin film and a fine-mesh material in the manner described in German Pat. Spec. No. 2,118,455.

For the detection of peroxidatively-active substances in feces, it is also possible to incorporate the activators according to the present invention, together with the reagents, in a water-stable film in the manner described in German Pat. Spec. No. 1,598,153. This has the advantage that the surface of the test strip can, for readingoff the color reaction, be cleaned by simply wiping it.

The following Examples are given for the purposes of illustrating the present invention:

g, EXAMPLE 1:

Filter paper is successively impregnated with the following solutions and dried'at' 40C.:

Solution 1 152M citrate buffer of pH 5.25

-con tinued g, v

distilled water ad l00.0 ml.

Solution 2.

o-tolidine 0.3 g. o-stilhazole 0.2 g. toluene ad l00.0 ml.

A'white test paper is obtained which, upon dipping into blood-containing urine, becomes blue-green colored after about 5 20 seconds. If the erythrocytes are intact, then the papers are blue-green speckled. If hemolysis has taken place or if free hemoglobin was initially present in the urine, then the papers are uniformly blue-green colored. The sensitivity is about 5 erythrocytes/mm or the corresponding amount of hemoglobin. A lower number of intact'er'ythrocytes can, under certain circumstances, still bring about'individual green dots on the test paper. The sensitivity with regard to myoglobin corresponds to that for hemoglobin.

Example 2:

Filter paper is impregnated with the followingsolutions and dried at 40C.:

Solution 1 Test papers are obtained with'practically the same properties as those described in Example I. The sensitivety is between about 5 and 20 erythrocytes/mm .'de-

creasing with the compound (I) used in the given order:

Compound I used:

pyridyl-2-pyridyl-3-ethylene di-(Pyridyl-Z)-ethylene 2-(4-methoxyphenylvinyl)-pyridine 2-(4-methylphenylvinyll-pyridine pyridyl-2-pyridyl-4-ethylene -continucd 2-( phenylvinyl 4-methylpyridine.

All the abovementioned compounds are known from the literature.

It will be understood that the foregoing specification and examples are illustrative but not limitative of the present invention inasmuch as other embodiments within the spirit and scope of the invention will suggest themselves to those skilled in the art.

What is claimed is:

1. Test strip composition for the detection of peroxidatively-active substances in body fluids, comprising a carrier containing a hydroperoxide, at least one chromogen and, as an activator, a compound of the formula:

wherein R is pyridyl or a phenyl optionally substituted by lower alkyl or alkoxy; and

R is hydrogen or lower alkyl.

2. Test strip as claimed in claim 1 and wherein R in the formula of said activator compound is pyridyl.

3. Test strip as claimed in claim 1 wherein R in the formula of said activator compound is phenyl.

4. Test strip as claimed in claim 1 wherein R in the formula of said activator compound is pyridyl substituted by methyl or methoxy.

5. Test strip as claimed in claim 1 wherein R in the formula of said activator compound is phenyl substituted by methyl or methoxy.

6. Test strip as claimed in claim 1 wherein R in the formula of said activator compound is hydrogen.

7. Test strip as claimed in claim 1 wherein R in the formula of said activator compound is methyl.

8. Test strip as claimed in claim 1 wherein said activator compound is Z-(phenylvinyl)-4-methylpyridine.

9. Test strip as claimed in claim 1 wherein said activator compound is pyridyl-2-pyridyl-4-ethylene.

10. Test strip as claimed in claim 1 wherein said activator compound is 2-(4-methylphenylvinyl)-pyridine.

11. Test strip as claimed in claim 1 wherein said activator compound is 2-(4-methoxyphenylvinyl)-pyridine.

12. Test strip as claimed in claim 1 wherein said activator compound is di-(pyridyl-2)-ethylene.

13. Test strip as claimed in claim 1 wherein said activator compound is pyridyl-2-pyridyl-3-ethylene.

14. Test strip as claimed in claim 1 wherein said activator compound is a-styryl-pyridine.

15. Test strip as claimed in claim 1 wherein said hydroperoxide is diisopropyl-benzene hydroperoxide or 2,5dimethylhexane-2,S-dihydroperoxide.

16. Test strip as claimed in claim 1 wherein said indicator is of the benzidine series or of the heterocyclic azine series.

17. Test strip as claimed in claim 1 wherein said composition also contains a small amount of a complex forming agent.

18. Test strip as claimed in claim 1 wherein said composition also contains a thickening agent.

19. Test strip as claimed in claim 1 wherein said composition also contains a wetting agent.

20. Test strip as claimed in claim 1 comprising citrate buffer ethylenediaminetetraacetic: acid, disodium salt dodecyl-benzene-sulfonic acid sodium salt 2,S-dimethylhexane-Z.S-dihydroperoxide phosphoric acid trimorpholide o-tolidine o-stilbazole.

21. Test strip as claimed in claim 1 wherein the carrier is an absorbent material impregnated with the reagents.

22. Test strip as claimed in claim 21 wherein the carrier is a water-stable film with the reagents incorporated therein.

23. Method of detecting a peroxidatively active substance in a body fluid which method comprises contacting a sample of said body fluid with a test strip composition as claimed in claim 1 and observing a color change in said test strip composition as an indication of the absence or presence of the peroxidatively active sub stance.

24. Method as claimed in claim 23 wherein said peroxidatively active substance is blood.

25. Method as claimed in claim 23 wherein said body fluid is urine.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US3558435 *Aug 4, 1967Jan 26, 1971Boehringer Mannheim GmbhDiagnostic agents for use in the determination of hydroperoxides and of peroxidate-active substances and methods for manufacturing and using the same
US3630847 *Jul 17, 1968Dec 28, 1971Boehringer Mannheim GmbhDiagnostic agent for use in the determination of hydroperoxides and of peroxidate-active substances
US3654179 *Mar 1, 1971Apr 4, 1972Miles LabIndicator for detecting hydrogen peroxide and peroxidative compounds containing bindschedler's green
US3654180 *Mar 1, 1971Apr 4, 1972Miles LabIndicator for detecting hydrogen peroxide and peroxidative compounds containing alpha naphthoflavone
US3853471 *Jul 3, 1973Dec 10, 1974Boehringer Mannheim GmbhDiagnostic composition for the detection of peroxidatively active substances in body fluids
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US4050898 *Apr 26, 1976Sep 27, 1977Eastman Kodak CompanyDetection of analyte dissolved in aqueous proteinaceous liquid
US4071317 *Mar 14, 1977Jan 31, 1978Miles Laboratories, Inc.Test composition and device for determining peroxidatively active substances and process for preparing same
US4071318 *Mar 14, 1977Jan 31, 1978Miles Laboratories, Inc.Hemoglobin
US4071321 *Mar 14, 1977Jan 31, 1978Miles Laboratories, Inc.Test composition and device for determining peroxidatively active substances
US4148611 *Jun 28, 1978Apr 10, 1979Miles Laboratories, Inc.Test composition, device and method for the detection of peroxidatively active substances
US4175923 *Jun 26, 1978Nov 27, 1979Friend William GApplying developing solution to an absorbent material impregnated with a guaiac reagent
US4251222 *Dec 17, 1979Feb 17, 1981Miles Laboratories, Inc.Sensitizers for peroxidative activity tests
US4251223 *Dec 17, 1979Feb 17, 1981Miles Laboratories, Inc.Sensitizers for peroxidative activity tests
US4278439 *Dec 17, 1979Jul 14, 1981Miles Laboratories, Inc.Benzimidazoles
US4299917 *Jan 21, 1980Nov 10, 1981Boehringer Manneheim GmbhImpregnation of an absorbent carrier with a sulphonphthalein ester and an activator
US4333734 *Oct 8, 1980Jun 8, 1982Sloan-Kettering Institute For Cancer ResearchDenaturing, proteins, peroxidase
US4339242 *Jul 23, 1981Jul 13, 1982Miles Laboratories, Inc.Alkylpyridine compounds
US4339243 *Jul 23, 1981Jul 13, 1982Miles Laboratories, Inc.A cyclohexanone
US4340392 *Jul 23, 1981Jul 20, 1982Miles Laboratories, Inc.Stabilization of benzidine-type indicators with various enhancers
US4340393 *Jul 23, 1981Jul 20, 1982Miles Laboratories, Inc.Stabilization of benzidine-type indicators with various enhancers
US4340394 *Jul 23, 1981Jul 20, 1982Miles Laboratories, Inc.Pyrrolidones
US4340395 *Jul 23, 1981Jul 20, 1982Miles Laboratories, Inc.Stabilization of benzidine-type indicators with various enhancers
US4380585 *Jul 23, 1981Apr 19, 1983Miles Laboratories, Inc.Stabilization of benzidine-type indicators with various enhancers
US4481295 *Jun 27, 1980Nov 6, 1984Behringwerke AktiengesellschaftSubstituted or condensed pyridines in a process for the detection of substances having a peroxidatic effect and a diagnostic agent containing such pyridines
US4615982 *Dec 11, 1984Oct 7, 1986Lawrence Paul JDimethyl sulfoxide solvent; sensitivity
US4670402 *Dec 27, 1985Jun 2, 1987Macherey-Nagel & Co.-ChemikalienhandelUse of benzimidazole derivatives for the detection of blood and other peroxidatically active substances in body fluids and excretion products
US4737457 *Feb 26, 1986Apr 12, 1988Eastman Kodak CompanyForming dye detectable at long wavelength
US4818702 *Mar 31, 1988Apr 4, 1989Litmus Concepts, Inc.Fecal occult blood test reagent
US4886760 *Jul 31, 1986Dec 12, 1989Savyon Diagnostics LimitedStable chemical compositions containing chromogenic materials, peroxides, and stabilizing chemicals
US4956300 *Oct 16, 1984Sep 11, 1990Helena Laboratories CorporationAdsorbent carrier having guaiac that will react with hemoglobin fresent to form a blue dye, oxidizers and binders
US5053342 *May 7, 1990Oct 1, 1991Litmus Concepts, Inc.Developer for detection of iron protoporphyrins using leuco dye indicators, hydroperoxide, modulator (chloroquine and/or quinacrine) and solvent; no dietary meat ingestion interference false positives
US5081040 *Jun 6, 1989Jan 14, 1992Helena Laboratories CorporationComposition and kit for testing for occult blood in human and animal excretions, fluids, or tissue matrixes
US5182191 *Sep 21, 1989Jan 26, 1993Pacific Biotech, Inc.Occult blood sampling device and assay
US5196167 *May 9, 1991Mar 23, 1993Helena Laboratories CorporationFecal occult blood test product with positive and negative controls
US5217874 *May 9, 1991Jun 8, 1993Helena Laboratories CorporationFecal occult blood test product with positive and negative controls
US5273888 *Apr 29, 1988Dec 28, 1993Helena Laboratories CorporationChemical test kit and method for determining the presence of blood in a specimen and for verifying the effectiveness of the chemicals
US5426032 *Nov 5, 1993Jun 20, 1995Lifescan, Inc.No-wipe whole blood glucose test strip
US5563042 *Mar 21, 1995Oct 8, 1996Lifescan, Inc.Whole blood glucose test strip
US5702913 *Jun 12, 1989Dec 30, 1997Helena Laboratories CorporationUsed for fetal specimens for occult blood
US5827677 *Feb 1, 1996Oct 27, 1998Universal LavelMethod and device for specifically detecting myoglobin using a non-discriminating peroxidase sensitive assay
US5843692 *Sep 30, 1997Dec 1, 1998Lifescan, Inc.Automatic initiation of a time interval for measuring glucose concentration in a sample of whole blood
US5885789 *Mar 20, 1997Mar 23, 1999Stc Technologies IncorporatedSpectrophotometry; useful for qualitative or quantitative analysis of hemoglobin obtained from bodily fluid
US6268162May 28, 1999Jul 31, 2001Lifescan, Inc.Reflectance measurement of analyte concentration with automatic initiation of timing
US6458326Nov 24, 1999Oct 1, 2002Home Diagnostics, Inc.Protective test strip platform
US6525330Feb 28, 2001Feb 25, 2003Home Diagnostics, Inc.Method of strip insertion detection
US6541266Feb 28, 2001Apr 1, 2003Home Diagnostics, Inc.Method for determining concentration of an analyte in a test strip
US6562625Feb 28, 2001May 13, 2003Home Diagnostics, Inc.Inserting test element into analytical meter system; measuring first optical property of test element; distinguishing test element by identifying predetermined relationship between first and second optical properties; selecting test type
US6821483Jun 24, 2002Nov 23, 2004Lifescan, Inc.Reagent strip for use in detection and monitoring glucose in erythrocytes
US6858401Sep 23, 2002Feb 22, 2005Lifescan, Inc.Minimum procedure system for the determination of analytes
US6881550Jun 24, 2002Apr 19, 2005Roger PhillipsMethod for the determination of glucose employing an apparatus emplaced matrix
US6887426Jun 24, 2002May 3, 2005Roger PhillipsReagent strip for use in detection and monitoring glucose in erythrocytes
US6979571Aug 1, 2002Dec 27, 2005Home Diagnostics, Inc.Method of using a protective test strip platform for optical meter apparatus
US7241627 *Oct 10, 2003Jul 10, 2007Kimberly-Clark Worldwide, Inc.Wearable article with multi-level alert system
US7390665Mar 4, 2003Jun 24, 2008Gilmour Steven BDistinguishing test types through spectral analysis
EP0014929A1 *Feb 11, 1980Sep 3, 1980Boehringer Mannheim GmbhDiagnostic means, process for its preparation and its use in determining leucocytes in body fluids
EP0029926A1 *Nov 4, 1980Jun 10, 1981Miles Laboratories, Inc.A composition and a test device based on a benzidine-type indicator for detecting the presence of a constituent in a test sample
EP0030683A1 *Dec 4, 1980Jun 24, 1981Miles Laboratories, Inc.Test composition for peroxidatively active substances, test device containing the composition, process for preparing same and method for the determination of peroxidatively active substances
Classifications
U.S. Classification436/66, 435/805, 436/904, 435/28, 422/420
International ClassificationG01N33/50, C12Q1/00, C12Q1/28
Cooperative ClassificationC12Q2326/00, C12Q1/28, Y10S435/805, Y10S436/904
European ClassificationC12Q1/28